Skip Navigation


Hum. Reprod. Advance Access originally published online on September 14, 2007
Human Reproduction 2007 22(11):2805-2813; doi:10.1093/humrep/dem270
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
22/11/2805    most recent
dem270v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huirne, J.A.
Right arrow Articles by Lambalk, C.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huirne, J.A.
Right arrow Articles by Lambalk, C.B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Are GnRH antagonists comparable to agonists for use in IVF?

J.A. Huirne, R. Homburg and C.B. Lambalk1

Division of Reproductive Medicine Department of Obstetrics and Gynaecology Vrije Universiteit medical centre (VUmc), PO Box 7075, 1007 MB Amsterdam, the Netherlands

1 Correspondence address. Tel: +0031-204440070; Fax: +0031-204440045; E-mail: cb.Lambalk{at}vumc.nl

We believe that appropriate comparison of optimal GnRH agonist and antagonist regimens has not been performed yet. Currently available meta-analyses included all comparative studies between GnRH agonists and antagonists performed so far, including less than optimal GnRH antagonist regimens. After critical appraisal of the various studied GnRH antagonist regimens in terms of follicular development and IVF outcome, we postulate that early suppression of endogenous FSH results in optimal follicular development. Additionally, stable and early suppression of LH and progesterone levels during the entire period of stimulation may be an advantage for implantation and pregnancy outcome. In this respect, single dose and particularly flexible protocols seem to be less advantageous. Early FSH and LH suppression can be achieved by early GnRH antagonist administration (stimulation day 1) or by oral contraceptive (OC) pretreatment. More studies comparing long GnRH agonist protocols with ‘long’ GnRH antagonist protocols, with enough power to identify differences in pregnancy rates, are required before appropriate comparison can be made.

Key words: GnRH agonists/GnRH antagonists/IVF/stimulation protocols/oral contraceptive pretreatment

Submitted on October 13, 2006; resubmitted on April 18, 2007; accepted on July 10, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
A. Allegra, A. Marino, F. Coffaro, A. Lama, G. Rizza, P. Scaglione, F. Sammartano, A. Santoro, and A. Volpes
Is there a uniform basal endometrial gene expression profile during the implantation window in women who became pregnant in a subsequent ICSI cycle?
Hum. Reprod., October 1, 2009; 24(10): 2549 - 2557.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. M. Nelson, R. W. Yates, H. Lyall, M. Jamieson, I. Traynor, M. Gaudoin, P. Mitchell, P. Ambrose, and R. Fleming
Anti-Mullerian hormone-based approach to controlled ovarian stimulation for assisted conception
Hum. Reprod., April 1, 2009; 24(4): 867 - 875.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
P. Devroey, M. Aboulghar, J. Garcia-Velasco, G. Griesinger, P. Humaidan, E. Kolibianakis, W. Ledger, C. Tomas, and B. C.J.M. Fauser
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment
Hum. Reprod., April 1, 2009; 24(4): 764 - 774.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
N. Gleicher and D. H. Barad
Androgen priming before ovarian stimulation for IVF
Hum. Reprod., December 1, 2008; 23(12): 2868 - 2870.
[Full Text] [PDF]

Home page
 Hum ReprodHome page
E. Bosch, C. Vidal, E. Labarta, C. Simon, J. Remohi, and A. Pellicer
Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists--a randomized study
Hum. Reprod., October 1, 2008; 23(10): 2346 - 2351.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.